Correlation Between Khiron Life and Universe Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Khiron Life and Universe Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Khiron Life and Universe Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Khiron Life Sciences and Universe Pharmaceuticals, you can compare the effects of market volatilities on Khiron Life and Universe Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Khiron Life with a short position of Universe Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Khiron Life and Universe Pharmaceuticals.

Diversification Opportunities for Khiron Life and Universe Pharmaceuticals

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Khiron and Universe is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Khiron Life Sciences and Universe Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universe Pharmaceuticals and Khiron Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Khiron Life Sciences are associated (or correlated) with Universe Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universe Pharmaceuticals has no effect on the direction of Khiron Life i.e., Khiron Life and Universe Pharmaceuticals go up and down completely randomly.

Pair Corralation between Khiron Life and Universe Pharmaceuticals

Assuming the 90 days horizon Khiron Life Sciences is expected to generate 1.26 times more return on investment than Universe Pharmaceuticals. However, Khiron Life is 1.26 times more volatile than Universe Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Universe Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest  0.01  in Khiron Life Sciences on December 23, 2024 and sell it today you would lose (0.01) from holding Khiron Life Sciences or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy98.36%
ValuesDaily Returns

Khiron Life Sciences  vs.  Universe Pharmaceuticals

 Performance 
       Timeline  
Khiron Life Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Khiron Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Universe Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Khiron Life and Universe Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Khiron Life and Universe Pharmaceuticals

The main advantage of trading using opposite Khiron Life and Universe Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Khiron Life position performs unexpectedly, Universe Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universe Pharmaceuticals will offset losses from the drop in Universe Pharmaceuticals' long position.
The idea behind Khiron Life Sciences and Universe Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk